Transient cold shock enhances zinc-finger nuclease-mediated gene disruption.

PubWeight™: 3.59‹?› | Rank: Top 1%

🔗 View Article (PMID 20436476)

Published in Nat Methods on May 02, 2010

Authors

Yannick Doyon1, Vivian M Choi, Danny F Xia, Thuy D Vo, Philip D Gregory, Michael C Holmes

Author Affiliations

1: Sangamo BioSciences, Richmond, California, USA. ydoyon@sangamo.com

Articles citing this

A TALE nuclease architecture for efficient genome editing. Nat Biotechnol (2010) 26.47

Genome editing with engineered zinc finger nucleases. Nat Rev Genet (2010) 18.88

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol (2013) 11.58

Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat Methods (2010) 6.00

Efficient TALEN-mediated gene knockout in livestock. Proc Natl Acad Sci U S A (2012) 4.99

Saturation editing of genomic regions by multiplex homology-directed repair. Nature (2014) 3.30

Surrogate reporters for enrichment of cells with nuclease-induced mutations. Nat Methods (2011) 3.22

Precision genome engineering with programmable DNA-nicking enzymes. Genome Res (2012) 3.05

Targeted chromosomal duplications and inversions in the human genome using zinc finger nucleases. Genome Res (2011) 2.85

Rapid and efficient clathrin-mediated endocytosis revealed in genome-edited mammalian cells. Nat Cell Biol (2011) 2.79

Optimization of scarless human stem cell genome editing. Nucleic Acids Res (2013) 2.78

Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases. Proc Natl Acad Sci U S A (2011) 2.61

Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nat Methods (2012) 2.07

Advances in targeted genome editing. Curr Opin Chem Biol (2012) 1.97

Autonomous zinc-finger nuclease pairs for targeted chromosomal deletion. Nucleic Acids Res (2010) 1.92

Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer. Nat Med (2012) 1.87

TALEN-based gene correction for epidermolysis bullosa. Mol Ther (2013) 1.84

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR. Blood (2012) 1.61

Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nat Genet (2013) 1.60

Quantifying genome-editing outcomes at endogenous loci with SMRT sequencing. Cell Rep (2014) 1.50

Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases. Mol Ther (2013) 1.26

Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases. Nucleic Acids Res (2011) 1.25

Magnetic separation and antibiotics selection enable enrichment of cells with ZFN/TALEN-induced mutations. PLoS One (2013) 1.17

Toward eliminating HLA class I expression to generate universal cells from allogeneic donors. Blood (2013) 1.17

TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity. Nucleic Acids Res (2014) 1.16

Zinc-finger nucleases: how to play two good hands. Nat Methods (2011) 1.08

p53 Gene repair with zinc finger nucleases optimised by yeast 1-hybrid and validated by Solexa sequencing. PLoS One (2011) 1.04

Functional footprinting of regulatory DNA. Nat Methods (2015) 1.04

Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases. Mol Ther (2015) 1.04

High-efficiency genome editing via 2A-coupled co-expression of fluorescent proteins and zinc finger nucleases or CRISPR/Cas9 nickase pairs. Nucleic Acids Res (2014) 0.98

Generation of interleukin-2 receptor gamma gene knockout pigs from somatic cells genetically modified by zinc finger nuclease-encoding mRNA. PLoS One (2013) 0.96

Implications of targeted genomic disruption of β-catenin in BxPC-3 pancreatic adenocarcinoma cells. PLoS One (2014) 0.96

Correction of the ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Gene by Zinc-Finger Nuclease Homology-Directed Repair. Biores Open Access (2012) 0.95

Genome editing with CompoZr custom zinc finger nucleases (ZFNs). J Vis Exp (2012) 0.93

A novel zinc-finger nuclease platform with a sequence-specific cleavage module. Nucleic Acids Res (2011) 0.92

mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5. Nucleic Acids Res (2015) 0.91

Efficient gene targeting by homology-directed repair in rat zygotes using TALE nucleases. Genome Res (2014) 0.89

Hepatitis C virus entry is impaired by claudin-1 downregulation in diacylglycerol acyltransferase-1-deficient cells. J Virol (2014) 0.89

Fanconi anemia gene editing by the CRISPR/Cas9 system. Hum Gene Ther (2015) 0.87

Simple and efficient methods for enrichment and isolation of endonuclease modified cells. PLoS One (2014) 0.87

Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions. Cell Stem Cell (2016) 0.87

Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs. Cell Regen (Lond) (2013) 0.86

Stability of zinc finger nuclease protein is enhanced by the proteasome inhibitor MG132. PLoS One (2013) 0.86

Tagging of genomic STAT3 and STAT1 with fluorescent proteins and insertion of a luciferase reporter in the cyclin D1 gene provides a modified A549 cell line to screen for selective STAT3 inhibitors. PLoS One (2013) 0.85

Novel lentiviral vectors with mutated reverse transcriptase for mRNA delivery of TALE nucleases. Sci Rep (2014) 0.85

Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zinc-finger nucleases. Hum Gene Ther Methods (2013) 0.84

Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic Melanoma. Mol Ther (2015) 0.84

Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates. Blood (2016) 0.84

TALEN-mediated modification of the bovine genome for large-scale production of human serum albumin. PLoS One (2014) 0.82

Establishment of HeLa cell mutants deficient in sphingolipid-related genes using TALENs. PLoS One (2014) 0.80

Improved cell-penetrating zinc-finger nuclease proteins for precision genome engineering. Mol Ther Nucleic Acids (2015) 0.80

Designer microbes for biosynthesis. Curr Opin Biotechnol (2014) 0.80

Generation of heterozygous fibrillin-1 mutant cloned pigs from genome-edited foetal fibroblasts. Sci Rep (2016) 0.79

Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery. Sci Rep (2014) 0.79

Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells. Mol Ther Methods Clin Dev (2016) 0.78

Targeted Gene Knockin in Porcine Somatic Cells Using CRISPR/Cas Ribonucleoproteins. Int J Mol Sci (2016) 0.77

Multidimensional Genome-wide Analyses Show Accurate FVIII Integration by ZFN in Primary Human Cells. Mol Ther (2015) 0.77

Marker-free coselection for CRISPR-driven genome editing in human cells. Nat Methods (2017) 0.77

Genome editing through large insertion leads to the skipping of targeted exon. BMC Genomics (2015) 0.76

TALENs targeting HBV: designer endonuclease therapies for viral infections. Mol Ther (2013) 0.76

Advances in genetic modification of farm animals using zinc-finger nucleases (ZFN). Chromosome Res (2015) 0.76

Generation of α1,3-galactosyltransferase and cytidine monophospho-N-acetylneuraminic acid hydroxylase gene double-knockout pigs. J Reprod Dev (2015) 0.76

pEVL: A Linear Plasmid for Generating mRNA IVT Templates With Extended Encoded Poly(A) Sequences. Mol Ther Nucleic Acids (2016) 0.76

Zinc Finger Nuclease: A New Approach to Overcome Beta-Lactam Antibiotic Resistance. Jundishapur J Microbiol (2016) 0.76

Precise gene editing paves the way for derivation of Mannheimia haemolytica leukotoxin-resistant cattle. Proc Natl Acad Sci U S A (2016) 0.75

TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality. Sci Rep (2015) 0.75

Traceless Targeting and Isolation of Gene-Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex Patients. Mol Ther Methods Clin Dev (2017) 0.75

Articles cited by this

An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol (2007) 17.80

Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol (2008) 14.75

Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat Biotechnol (2008) 14.20

Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol (2009) 12.40

Knockout rats via embryo microinjection of zinc-finger nucleases. Science (2009) 12.33

Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell (2008) 11.24

Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases. Nat Biotechnol (2008) 10.29

Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nat Biotechnol (2007) 8.88

Rapid mutation of endogenous zebrafish genes using zinc finger nucleases made by Oligomerized Pool ENgineering (OPEN). PLoS One (2009) 6.67

Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci U S A (2008) 6.59

Induction and repair of zinc-finger nuclease-targeted double-strand breaks in Caenorhabditis elegans somatic cells. Proc Natl Acad Sci U S A (2006) 6.00

Efficient gene targeting in Drosophila with zinc-finger nucleases. Genetics (2006) 4.47

Generation of knockout rats with X-linked severe combined immunodeficiency (X-SCID) using zinc-finger nucleases. PLoS One (2010) 3.09

Expanding or restricting the target site repertoire of zinc-finger nucleases: the inter-domain linker as a major determinant of target site selectivity. Mol Ther (2008) 3.02

Biochemical insights into the mechanisms central to the response of mammalian cells to cold stress and subsequent rewarming. FEBS J (2008) 1.24

Articles by these authors

A TALE nuclease architecture for efficient genome editing. Nat Biotechnol (2010) 26.47

Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature (2005) 19.15

Genome editing with engineered zinc finger nucleases. Nat Rev Genet (2010) 18.88

An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol (2007) 17.80

Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol (2008) 14.75

Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat Biotechnol (2008) 14.20

Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol (2009) 12.40

Knockout rats via embryo microinjection of zinc-finger nucleases. Science (2009) 12.33

Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol (2011) 11.76

Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci U S A (2007) 11.46

An expanded genome-scale model of Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biol (2003) 10.46

Targeted genome editing across species using ZFNs and TALENs. Science (2011) 9.84

Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol (2007) 9.23

Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell (2010) 8.79

Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol (2011) 8.45

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med (2014) 7.64

A rapid and general assay for monitoring endogenous gene modification. Methods Mol Biol (2010) 6.77

Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci U S A (2008) 6.59

Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell (2011) 6.56

Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol (2010) 6.55

An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol (2011) 6.44

Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat Methods (2010) 6.00

Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci U S A (2007) 5.93

Histone deimination antagonizes arginine methylation. Cell (2004) 5.19

Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature (2011) 4.92

In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature (2011) 4.81

Precise genome modification in the crop species Zea mays using zinc-finger nucleases. Nature (2009) 4.71

Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Res (2010) 3.94

Controlling long-range genomic interactions at a native locus by targeted tethering of a looping factor. Cell (2012) 2.87

Expanded metabolic reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an in silico genome-scale characterization of single- and double-deletion mutants. J Bacteriol (2005) 2.82

Rapid and efficient clathrin-mediated endocytosis revealed in genome-edited mammalian cells. Nat Cell Biol (2011) 2.79

Chromosomal translocations induced at specified loci in human stem cells. Proc Natl Acad Sci U S A (2009) 2.73

Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases. Proc Natl Acad Sci U S A (2011) 2.61

Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homology. Nucleic Acids Res (2010) 2.61

TRF2 associates with DREF and directs promoter-selective gene expression in Drosophila. Nature (2002) 2.48

Targeted transgene integration in plant cells using designed zinc finger nucleases. Plant Mol Biol (2008) 2.40

Site-specific integration and tailoring of cassette design for sustainable gene transfer. Nat Methods (2011) 2.30

Candidate metabolic network states in human mitochondria. Impact of diabetes, ischemia, and diet. J Biol Chem (2004) 2.26

Zinc-finger protein-targeted gene regulation: genomewide single-gene specificity. Proc Natl Acad Sci U S A (2003) 2.24

Generation of a triple-gene knockout mammalian cell line using engineered zinc-finger nucleases. Biotechnol Bioeng (2010) 2.23

DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation. PLoS Genet (2011) 2.22

Targeted gene addition to a predetermined site in the human genome using a ZFN-based nicking enzyme. Genome Res (2012) 2.02

Gene-specific targeting of H3K9 methylation is sufficient for initiating repression in vivo. Curr Biol (2002) 1.90

Efficient targeted gene disruption in the soma and germ line of the frog Xenopus tropicalis using engineered zinc-finger nucleases. Proc Natl Acad Sci U S A (2011) 1.90

Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection. Blood (2013) 1.80

Site-specific genome editing in Plasmodium falciparum using engineered zinc-finger nucleases. Nat Methods (2012) 1.79

Translating dosage compensation to trisomy 21. Nature (2013) 1.75

Efficient immunoglobulin gene disruption and targeted replacement in rabbit using zinc finger nucleases. PLoS One (2011) 1.69

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR. Blood (2012) 1.61

An engineered zinc finger protein activator of the endogenous glial cell line-derived neurotrophic factor gene provides functional neuroprotection in a rat model of Parkinson's disease. J Neurosci (2010) 1.59

Targeted gene addition to human mesenchymal stromal cells as a cell-based plasma-soluble protein delivery platform. Cytotherapy (2010) 1.58

Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases. PLoS Pathog (2011) 1.50

Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A. Proc Natl Acad Sci U S A (2013) 1.50

Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases. Mol Ther (2013) 1.49

BAK and BAX deletion using zinc-finger nucleases yields apoptosis-resistant CHO cells. Biotechnol Bioeng (2010) 1.46

In vivo cleavage of transgene donors promotes nuclease-mediated targeted integration. Biotechnol Bioeng (2012) 1.45

Cancer translocations in human cells induced by zinc finger and TALE nucleases. Genome Res (2013) 1.44

Enhanced protein production by engineered zinc finger proteins. Biotechnol Bioeng (2007) 1.26

Derivation and characterization of a simian immunodeficiency virus SIVmac239 variant with tropism for CXCR4. J Virol (2009) 1.24

Isogenic human cell lines for drug discovery: regulation of target gene expression by engineered zinc-finger protein transcription factors. J Biomol Screen (2005) 1.21

Toward eliminating HLA class I expression to generate universal cells from allogeneic donors. Blood (2013) 1.17

Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5. Hum Gene Ther (2013) 1.14

Highly efficient deletion of FUT8 in CHO cell lines using zinc-finger nucleases yields cells that produce completely nonfucosylated antibodies. Biotechnol Bioeng (2010) 1.12

Robust ZFN-mediated genome editing in adult hemophilic mice. Blood (2013) 1.11